Medical Developments UK (MDUK) has announced that it will donate 25p from the sale of each of its pMDI spacers in the UK to Asthma UK. MDUK is part of Medical Developments International, whose Space Chamber line of valved holding chambers was launched in the spring of 2013. The company also markets a portable nebulizer. Asthma UK Clinical Lead Deborah Waddell … [Read more...] about Spacer manufacturer Medical Developments partners with Asthma UK
News
Formex names Steve Massah President and CEO
CDMO Formex, formerly PharmaForm, has hired Steve Massah as President and CEO. Massah joins Formex from Gilead, where he worked in Strategic Drug Product Manufacturing and Outsourcing. He has previously held management positions with Avanir, ISTA, and Neurocrine Biosciences. Formex Chairman Masood Tayebi commented, "Steve brings a wealth of knowledge and expertise … [Read more...] about Formex names Steve Massah President and CEO
St. Renatus gets $5 million additional funding for nasal dental anesthetic
According to St. Renatus, Blue Ocean Holdings is investing an additional $5 million in the company. The funds will go toward completion of St. Renatus's New Drug Application (NDA) for its nasal mist dental anesthesia and for commercialization. St. Renatus says that it plans to submit the NDA in 2014. In February 2014, St. Renatus announced that it had completed … [Read more...] about St. Renatus gets $5 million additional funding for nasal dental anesthetic
GSK announces that Phase 3 study results show Anoro Ellipta improves lung function more than Advair Diskus
GSK and Theravance have announced that results from three phase 3 studies comparing the Anoro Ellipta umeclidinium/vilanterol DPI to Advair and Seretide Diskus in COPD patients show greater improvement in lung function for patients treated with Anoro Ellipta. The three randomized, double-blind, double-dummy, parallel group studies involved a total of about 2,100 … [Read more...] about GSK announces that Phase 3 study results show Anoro Ellipta improves lung function more than Advair Diskus
Adasuve launched in Romania
Alexza Pharmaceuticals has announced that its European partner Ferrer has launched Adasuve loxapine inhalation powder for the treatment of agitation in schizophrenic or bipolar patients in Romania. Ferrer has a distribution agreement with Galenica for distribution in that country. In the US, Teva launched the product earlier this month. Alexza President and CEO … [Read more...] about Adasuve launched in Romania
Vectura acquires Activaero for €130 million
Vectura has announced that it will acquire Activaero for a total of €130 million ($181 million). The company cited both Activaero's nebulizer technology and its pipeline of respiratory drugs as part of the rationale for the acquisition, saying that the deal "extends Vectura's technology platform into smart nebulizer-based technology, broadening Vectura's therapeutic … [Read more...] about Vectura acquires Activaero for €130 million
Hunein Maassab, developer of FluMist, has died
The New York Times has reported that Hunein "John" Maassab, who developed the FluMist intranasal live attenuated influenza vaccine (LAIV), died on February 1, 2014 in North Carolina. Dr. Maassab received a doctorate in epidemiology from the University of Michigan in 1956 and subsequently joined the faculty of the School of Public Health at Michigan. He retired at the … [Read more...] about Hunein Maassab, developer of FluMist, has died
Hi-Tech Pharmacal reports large drop in nasal spray sales
According to Hi-Tech Pharmacal, sales of its fluticasone propionate nasal spray dropped from $23 million in the 3rd quarter of the 2013 fiscal year to only $10.9 million for the same period in 2014. The decrease was a combination of lower unit sales and a lower average price, the company said. Sales of a homeopathic OTC nasal spray called Sinus Buster marketed by … [Read more...] about Hi-Tech Pharmacal reports large drop in nasal spray sales
Gerresheimer expands US inhaler manufacturing capacity
Device manufacturer Gerresheimer has announced that it is adding 60,000 sq ft to its production facility in Peachtree City, GA in order to accommodate increased demand for inhalers and other plastic medical devices. Approximately 40,000 sq ft of the expansion will be devoted to ISO class 8 clean room space. The company says that it will spend "double digit million … [Read more...] about Gerresheimer expands US inhaler manufacturing capacity
Verona looking to raise up to £14 million for development of inhaled drugs
Verona Pharma has announced that it is looking to raise up to £14 million through a placing, subscription, and open offer of more than 630 million new ordinary shares, conditioned on approval of shareholders. A general meeting will be held on March 24 2014. According to the company, the proceeds would be used for development of its inhaled dual phosphodiesterase (PDE) … [Read more...] about Verona looking to raise up to £14 million for development of inhaled drugs